AGM Details

  • Date and Time: Tuesday, September 29, 2026 at 02:00 PM IST
  • Mode: Video Conferencing/Other Audio-Visual Means (VC/OAVM)
  • Cut-off date for e-voting: Tuesday, September 22, 2026
  • E-voting period: September 25, 2026 (9:00 AM) to September 28, 2026 (5:00 PM)
  • Record Date for dividend: Tuesday, September 22, 2026
  • Book Closure: September 23, 2026 to September 29, 2026

Dividend Recommendation

  • Final Dividend: Re. 1/- (Rupee One Only) per equity share of face value ₹10/- each
  • Subject to: Deduction of tax at source and provisions of Section 123 of Companies Act, 2013

Ordinary Business Items

1. Adoption of Financial Statements

To receive, consider and adopt Audited Financial Statements (Standalone) for FY ended March 31, 2026 together with Reports of Board of Directors and Auditors.

2. Declaration of Dividend

To declare dividend at rate of Re. 1/- per equity share for FY ended March 31, 2026 as recommended by Board.

3. Re-appointment of Managing Director

Re-appointment of Mr. Sanjay Lalbhadur Upadhaya (DIN: 07497306) who retires by rotation and offers himself for re-appointment as Managing Director.

4. Re-appointment of Statutory Auditors

Appointment of M/s. S D P M & Co., Chartered Accountants (Firm Registration No. 126741W) as Statutory Auditors for second term of 5 consecutive years from conclusion of 34th AGM until conclusion of 39th AGM.

  • Annual Audit Fee: ₹3,00,000/- plus applicable taxes and reimbursement of out-of-pocket expenses

Special Business Items

5. Ratification of Cost Auditor Remuneration

Ratification of remuneration payable to M/s. J.H. Survase & Co., Cost Accountants for conducting cost audit for FY ending March 31, 2027.

  • Remuneration: ₹1,60,000/- plus taxes and reimbursement of out-of-pocket expenses

6. Borrowing Limits Approval

Approval under Section 180(1)(c) for borrowing monies exceeding aggregate of paid-up capital, free reserves and securities premium.

  • Limit: Up to ₹1000 Crore (Rupees One Thousand Crore Only) or aggregate of paid-up capital, free reserves and securities premium, whichever is higher

7. Creation of Charges on Assets

Approval under Section 180(1)(a) for creation of mortgage/charge on assets, properties or undertakings to secure borrowing facilities.

8. Loans and Investments Approval

Approval under Section 186 for giving loans, inter-corporate deposits, guarantees, and acquiring securities of other body corporates.

  • Limit: Up to 60% of paid-up capital plus free reserves and securities premium account or 100% of free reserves and securities premium account or ₹1000 Crore, whichever is higher

9. Increase in Authorized Share Capital

Increase in Authorized Share Capital from ₹25.05 Crore to ₹50.00 Crore divided into 5,00,00,000 equity shares of ₹10/- each.

  • Current: ₹25,05,00,000 divided into 2,50,50,000 equity shares
  • Proposed: ₹50,00,00,000 divided into 5,00,00,000 equity shares

10. Preferential Share Issuance for Acquisition

Issuance of 7,15,040 equity shares on preferential basis for consideration other than cash towards acquisition of 51% stake in:

1. Matrix Labs Diagnocare Private Limited (MLDPL)

2. Matrix Labs Private Limited (MLPL)

Acquisition Details:

  • Total Consideration: ₹39.54 Crore (₹35.98 Crore for MLDPL + ₹3.56 Crore for MLPL)
  • Issue Price: ₹553 per share (Face value ₹10 + Premium ₹543)
  • Allottees: Mr. Suresh and Ms. Nithya S for MLDPL; Mr. Suresh for MLPL
  • Share Allocation:
  • Mr. Suresh (MLDPL): 6,01,760 shares (47.27% stake)
  • Ms. Nithya S (MLDPL): 48,840 shares (3.84% stake)
  • Mr. Suresh (MLPL): 64,440 shares (51% stake)

Valuation:

  • Conducted by M/s. Samvritti Valuation (OPC) Private Limited, IBBI Registered Valuer
  • Fair value of One Global shares: ₹553 each
  • Fair value of MLDPL shares: ₹27,007.88 each
  • Fair value of MLPL shares: ₹13,973.77 each

Lock-in: Equity shares subject to lock-in as per SEBI ICDR Regulations

11. Material Related Party Transactions

Approval for material related party transactions with Lifenity Health Limited (LHL) for aggregate value of ₹500 Crore for period from 34th AGM to 35th AGM in 2027.

Transaction Breakdown:

  • Purchase of Goods: ₹15.00 Crore
  • Sale of Goods: ₹20.00 Crore
  • Availing/Rendering of Services: ₹435.00 Crore
  • Purchase of Assets: ₹15.00 Crore
  • Sale/Transfer of Assets: ₹15.00 Crore

Financial Highlights (FY 2025-26)

  • Total Revenue: ₹49,881.06 Lakhs (FY 2024-25: ₹14,784.17 Lakhs)
  • Profit After Tax: ₹6,950.42 Lakhs (FY 2024-25: ₹1,846.66 Lakhs)
  • Net Worth: ₹14,122.84 Lakhs (FY 2024-25: ₹7,172.42 Lakhs)
  • Return on Equity: 49.21% (FY 2024-25: 25.75%)
  • Earnings Per Share: ₹35.56 (FY 2024-25: ₹9.45)

Corporate Governance

  • Board Composition: 4 Directors (1 Executive, 3 Independent)
  • Board Meetings: 8 meetings held during FY 2025-26
  • Key Committees: Audit Committee, Nomination & Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee
  • CSR Spending: ₹25.00 Lakhs against obligation of ₹23.77 Lakhs

Auditors

  • Statutory Auditors: M/s. S D P M & Co., Chartered Accountants
  • Internal Auditors: M/s. Rushil Soni & Co., Chartered Accountants
  • Secretarial Auditors: M/s. M K Samdani & Co., Company Secretaries
  • Cost Auditors: M/s. J.H. Survase & Co., Cost Accountants

Other Information

  • RTA: MCS Share Transfer Agent Limited